These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12646038)

  • 1. Influence of the 5-HT6 receptor on acetylcholine release in the cortex: pharmacological characterization of 4-(2-bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine, a potent and selective 5-HT6 receptor antagonist.
    Riemer C; Borroni E; Levet-Trafit B; Martin JR; Poli S; Porter RH; Bös M
    J Med Chem; 2003 Mar; 46(7):1273-6. PubMed ID: 12646038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models.
    Hirst WD; Stean TO; Rogers DC; Sunter D; Pugh P; Moss SF; Bromidge SM; Riley G; Smith DR; Bartlett S; Heidbreder CA; Atkins AR; Lacroix LP; Dawson LA; Foley AG; Regan CM; Upton N
    Eur J Pharmacol; 2006 Dec; 553(1-3):109-19. PubMed ID: 17069795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of localization of 5-HT6 receptors on cholinergic neurons: implication of multiple neurotransmitter systems in 5-HT6 receptor-mediated acetylcholine release.
    Marcos B; Gil-Bea FJ; Hirst WD; García-Alloza M; Ramírez MJ
    Eur J Neurosci; 2006 Sep; 24(5):1299-306. PubMed ID: 16987217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bicyclic heteroarylpiperazines as selective brain penetrant 5-HT6 receptor antagonists.
    Ahmed M; Briggs MA; Bromidge SM; Buck T; Campbell L; Deeks NJ; Garner A; Gordon L; Hamprecht DW; Holland V; Johnson CN; Medhurst AD; Mitchell DJ; Moss SF; Powles J; Seal JT; Stean TO; Stemp G; Thompson M; Trail B; Upton N; Winborn K; Witty DR
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4867-71. PubMed ID: 16143522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of 5-HT 1B receptors facilitates contextual aversive learning in mice by disinhibition of cholinergic and glutamatergic neurotransmission.
    Eriksson TM; Madjid N; Elvander-Tottie E; Stiedl O; Svenningsson P; Ogren SO
    Neuropharmacology; 2008 Jun; 54(7):1041-50. PubMed ID: 18394658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 8-Sulfonyl-substituted tetrahydro-1H-pyrido[4,3-b]indoles as 5-HT6 receptor antagonists.
    Ivachtchenko AV; Mitkin OD; Tkachenko SE; Okun IM; Kysil VM
    Eur J Med Chem; 2010 Feb; 45(2):782-9. PubMed ID: 19939513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Piperazinyl-3-sulfonylindazoles as potent and selective 5-hydroxytryptamine-6 antagonists.
    Liu KG; Robichaud AJ; Bernotas RC; Yan Y; Lo JR; Zhang MY; Hughes ZA; Huselton C; Zhang GM; Zhang JY; Kowal DM; Smith DL; Schechter LE; Comery TA
    J Med Chem; 2010 Nov; 53(21):7639-46. PubMed ID: 20932009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of the structure of 4, 6-disubstituted 2-(4-alkyl-1-piperazinyl)pyridines: synthesis and their 5-HT2A receptor activity.
    Paluchowska MH; Bojarski AJ; Bugno R; Charakchieva-Minol S; Wesołowska A
    Arch Pharm (Weinheim); 2003 Apr; 336(2):104-10. PubMed ID: 12761763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a potent and selective 5-HT(6) antagonist: one-step synthesis of (E)-3-(benzenesulfonyl)-2- (methylsulfanyl)pyrido[1,2-a]pyrimidin-4-ylidenamine from 2-(benzenesulfonyl)-3,3-bis(methylsulfanyl)acrylonitrile.
    Wu YJ; He H; Hu S; Huang Y; Scola PM; Grant-Young K; Bertekap RL; Wu D; Gao Q; Li Y; Klakouski C; Westphal RS
    J Med Chem; 2003 Nov; 46(23):4834-7. PubMed ID: 14584934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of N1-(6-chloroimidazo[2,1-b][1,3]thiazole-5-sulfonyl)tryptamine as a potent, selective, and orally active 5-HT(6) receptor agonist.
    Cole DC; Stock JR; Lennox WJ; Bernotas RC; Ellingboe JW; Boikess S; Coupet J; Smith DL; Leung L; Zhang GM; Feng X; Kelly MF; Galante R; Huang P; Dawson LA; Marquis K; Rosenzweig-Lipson S; Beyer CE; Schechter LE
    J Med Chem; 2007 Nov; 50(23):5535-8. PubMed ID: 17948978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel 1-(azacyclyl)-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines as 5-HT6 agonists and antagonists.
    Elokdah H; Li D; McFarlane G; Bernotas RC; Robichaud AJ; Magolda RL; Zhang GM; Smith D; Schechter LE
    Bioorg Med Chem; 2007 Sep; 15(18):6208-26. PubMed ID: 17624788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlating efficacy in rodent cognition models with in vivo 5-hydroxytryptamine1a receptor occupancy by a novel antagonist, (R)-N-(2-methyl-(4-indolyl-1-piperazinyl)ethyl)-N-(2-pyridinyl)-cyclohexane carboxamide (WAY-101405).
    Hirst WD; Andree TH; Aschmies S; Childers WE; Comery TA; Dawson LA; Day M; Feingold IB; Grauer SM; Harrison BL; Hughes ZA; Kao J; Kelly MG; van der Lee H; Rosenzweig-Lipson S; Saab AL; Smith DL; Sullivan K; Rizzo SJ; Tio C; Zhang MY; Schechter LE
    J Pharmacol Exp Ther; 2008 Apr; 325(1):134-45. PubMed ID: 18182558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of 7-arylsulfonyl-1,2,3,4, 4a,9a-hexahydro-benzo[4,5]furo[2,3-c]pyridines: identification of a potent and selective 5-HT₆ receptor antagonist showing activity in rat social recognition test.
    Tripathy R; McHugh RJ; Bacon ER; Salvino JM; Morton GC; Aimone LD; Huang Z; Mathiasen JR; DiCamillo A; Huffman MJ; McKenna BA; Kopec K; Lu LD; Qian J; Angeles TS; Connors T; Spais C; Holskin B; Duzic E; Schaffhauser H; Rossé GC
    Bioorg Med Chem Lett; 2012 Feb; 22(3):1421-6. PubMed ID: 22226656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lecozotan (SRA-333): a selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties.
    Schechter LE; Smith DL; Rosenzweig-Lipson S; Sukoff SJ; Dawson LA; Marquis K; Jones D; Piesla M; Andree T; Nawoschik S; Harder JA; Womack MD; Buccafusco J; Terry AV; Hoebel B; Rada P; Kelly M; Abou-Gharbia M; Barrett JE; Childers W
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1274-89. PubMed ID: 15951399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
    Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P
    J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2,5-Disubstituted pyridines: the discovery of a novel series of 5-HT2A ligands.
    Wilson KJ; van Niel MB; Cooper L; Bloomfield D; O'Connor D; Fish LR; MacLeod AM
    Bioorg Med Chem Lett; 2007 May; 17(9):2643-8. PubMed ID: 17314044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Substituted 5,6-dimethyl-3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidines: new series of highly potent and specific serotonin 5-HT6 receptor antagonists.
    Ivachtchenko AV; Golovina ES; Kadieva MG; Koryakova AG; Mitkin OD; Tkachenko SE; Kysil VM; Okun I
    Eur J Med Chem; 2011 Apr; 46(4):1189-97. PubMed ID: 21333408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-(Phenylsulfonyl)piperidines: novel, selective, and bioavailable 5-HT(2A) receptor antagonists.
    Fletcher SR; Burkamp F; Blurton P; Cheng SK; Clarkson R; O'Connor D; Spinks D; Tudge M; van Niel MB; Patel S; Chapman K; Marwood R; Shepheard S; Bentley G; Cook GP; Bristow LJ; Castro JL; Hutson PH; MacLeod AM
    J Med Chem; 2002 Jan; 45(2):492-503. PubMed ID: 11784153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, biological activity, and molecular modeling of selective 5-HT(2C/2B) receptor antagonists.
    Forbes IT; Dabbs S; Duckworth DM; Ham P; Jones GE; King FD; Saunders DV; Blaney FE; Naylor CB; Baxter GS; Blackburn TP; Kennett GA; Wood MD
    J Med Chem; 1996 Dec; 39(25):4966-77. PubMed ID: 8960557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of 3-aryl-3-methyl-1H-quinoline-2,4-diones as a new class of selective 5-HT6 receptor antagonists.
    Seong CM; Park WK; Park CM; Kong JY; Park NS
    Bioorg Med Chem Lett; 2008 Jan; 18(2):738-43. PubMed ID: 18053713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.